| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/12/2006 | WO2006088664A3 Flavivirus ns5a proteins for the treatment of hiv |
| 10/12/2006 | WO2006085092A3 Methods and uses of antibodies in the purification of interferon |
| 10/12/2006 | WO2006073786A3 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| 10/12/2006 | WO2006071840A8 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 10/12/2006 | WO2006071603A3 Phosphodiesterase 4d in the ryanodine receptor complex protects against heart failure |
| 10/12/2006 | WO2006069739A3 Polypeptide species useful for the treatment of neurological disorders |
| 10/12/2006 | WO2006063865A3 Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing osmrbeta as a subunit, and applications thereof |
| 10/12/2006 | WO2006062402A3 Heat shock proteins (hsp) and supraventricular arrhythmia |
| 10/12/2006 | WO2006033888A3 A process to treat avascular necrosis (avn) with osteoinductive materials |
| 10/12/2006 | WO2006031388A3 Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
| 10/12/2006 | WO2006009694A3 Crystal of egfr extracellular domain and cetuximab fab fragment and uses thereof |
| 10/12/2006 | WO2005123113A3 Interferon compositions and methods of use thereof |
| 10/12/2006 | WO2005117954A3 Compositions and methods for treatment of neovascular diseases |
| 10/12/2006 | WO2005097200A3 Tetanus toxin fusion protein for visualization of active synapses |
| 10/12/2006 | WO2005078848A3 Inhibition of tumor growth and invasion by anti-matrix metalloproteinase dnazymes |
| 10/12/2006 | WO2005070445A3 Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
| 10/12/2006 | WO2005030132A3 Therapeutic regimens for administering drug combinations |
| 10/12/2006 | WO2004062621A3 Anti-inflammatory agents and methods of their use |
| 10/12/2006 | WO2004058088A3 Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries |
| 10/12/2006 | US20060230467 Plant deoxyribonucleoside kinase enzymes and their use |
| 10/12/2006 | US20060229588 Irrigation solution and method for inhibition of pain and inflammation |
| 10/12/2006 | US20060229470 Calcium receptor-active molecules |
| 10/12/2006 | US20060229436 activation of alpha-lactalbumin comprising contacting (in molten globule-like state) with fatty acids and lipids found in milk fractions containing casein obtained from humans; antibacterial agents; anticancer agents |
| 10/12/2006 | US20060229435 Lymphocyte homing receptors |
| 10/12/2006 | US20060229434 Low-molecular weight peptides inhibiting ion channel activity |
| 10/12/2006 | US20060229433 Modified antiviral peptides with increased activity and cell membrane affinity |
| 10/12/2006 | US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides |
| 10/12/2006 | US20060229356 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions |
| 10/12/2006 | US20060229345 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome |
| 10/12/2006 | US20060229340 Composition for improving cognition and memory |
| 10/12/2006 | US20060229288 Adjust concentration of oocytes in cells of mammals ; stimulant of ovaries follicular growth |
| 10/12/2006 | US20060229283 Cholesterol as an antibiotic for streptococcus pneumoniae |
| 10/12/2006 | US20060229259 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure |
| 10/12/2006 | US20060229257 For inhibiting thrombin in the prophylaxis or therapy of disease |
| 10/12/2006 | US20060229256 Enternal administration of arginine and glutamine for abnormal vascular proliferation |
| 10/12/2006 | US20060229255 Identification of n-alkylglycine trimers for induction of apoptosis |
| 10/12/2006 | US20060229254 Compounds having prolyl oligopeptidase inhibitory activity |
| 10/12/2006 | US20060229253 Pentapeptide compounds and uses related thereto |
| 10/12/2006 | US20060229252 Antimicrobial hexapeptides |
| 10/12/2006 | US20060229251 Disrupting sex steroid signal to thymus; bone marrow or hematopoitic cells |
| 10/12/2006 | US20060229250 Ghrelin associated peptide and its uses |
| 10/12/2006 | US20060229249 Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same |
| 10/12/2006 | US20060229248 Use of GLP-1 compound for treatment of critically ill patients |
| 10/12/2006 | US20060229247 T. cruzi-derived neurotrophic agents and methods of use therefor |
| 10/12/2006 | US20060229246 Peptide-enhanced transfections |
| 10/12/2006 | US20060229245 Lyophilized HGF preparations |
| 10/12/2006 | US20060229244 Engineered bacteriocins and bacteriocin combinations and methods for treating bacterial based infections |
| 10/12/2006 | US20060229243 Aequorin-containing compositions and methods of using same |
| 10/12/2006 | US20060229242 Composition comprising a pulmonary surfactant and a pde2 inhibitor |
| 10/12/2006 | US20060229241 Hypoxia induced mitogenic factor |
| 10/12/2006 | US20060229240 Point mutations; solid phase synthesis; for treating conditions characterized by decreases in bone mass such as osteoporosis |
| 10/12/2006 | US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 10/12/2006 | US20060229238 Sustained release of microcrystalline peptide suspensions |
| 10/12/2006 | US20060229237 Treatment of gastrointestinal distress |
| 10/12/2006 | US20060229236 Cyclic tetrapeptide compound and use thereof |
| 10/12/2006 | US20060229235 Target-binding motif linked to a 3 beta-cholesterylamine derivative membrane-binding element by a beta-alanine subunit; for delivering a protein, peptide, drug, prodrug, lipid, nucleic acid, carbohydrate or small molecule into a target cell via receptor-mediated endocytosis |
| 10/12/2006 | US20060229234 Peptide factor |
| 10/12/2006 | US20060229233 Compositions and methods for treating neurological disorders |
| 10/12/2006 | US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
| 10/12/2006 | US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 10/12/2006 | US20060228775 Differential expression of nucleic acid molecules |
| 10/12/2006 | US20060228773 Method for preparing recombinant heterocarpine |
| 10/12/2006 | US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity |
| 10/12/2006 | US20060228752 Genetic polymorphisms in the preprotachykinin gene |
| 10/12/2006 | US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy |
| 10/12/2006 | US20060228709 Novel fibulin-like polypeptides |
| 10/12/2006 | US20060228700 Novel retrovirus associated with myelodysplastic syndromes and uses thereof |
| 10/12/2006 | US20060228694 Methods to individualize combination therapy |
| 10/12/2006 | US20060228426 Plant extracts for treatment of angiogenesis and metastasis |
| 10/12/2006 | US20060228422 Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration |
| 10/12/2006 | US20060228420 Pharmaceutical compositions comprising microparticles for delivery into neurons |
| 10/12/2006 | US20060228418 Topical ointment and method for making and using same |
| 10/12/2006 | US20060228417 Mucoadhesive composition comprising polyacrylate and chemoattractant |
| 10/12/2006 | US20060228416 Methods for modulating topical inflammatory response |
| 10/12/2006 | US20060228414 Method for the preparation of controlled release formulations |
| 10/12/2006 | US20060228407 Enhanced delivery via serpin enzyme complex receptor |
| 10/12/2006 | US20060228401 Templating an extracellular biopolymer matrix for use in generating corneal stroma, and other structured connective tissue such as a ligament, a tendon, a fascia and annulus fibrosis; improved process control |
| 10/12/2006 | US20060228398 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections |
| 10/12/2006 | US20060228394 Ocular solutions |
| 10/12/2006 | US20060228393 Ocular solutions |
| 10/12/2006 | US20060228392 capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an osteoblast |
| 10/12/2006 | US20060228385 Sustained release of microcrystalline peptide suspensions |
| 10/12/2006 | US20060228372 Methods for modulating angiogenesis |
| 10/12/2006 | US20060228371 Immunological control of beta-amyloid levels in vivo |
| 10/12/2006 | US20060228365 Protein and gene involved in myocyte differentiation |
| 10/12/2006 | US20060228359 antibody; host cell; hybridoma; |
| 10/12/2006 | US20060228353 PTH1R and PTH3R receptors, methods and uses thereof |
| 10/12/2006 | US20060228348 Targeting of glycoprotein therapeutics |
| 10/12/2006 | US20060228347 Antitumor agent and dnase |
| 10/12/2006 | US20060228346 Constitutively active phosphatidylinositol 3-kinase and uses thereof |
| 10/12/2006 | US20060228345 Osteogenesis promoter |
| 10/12/2006 | US20060228344 Cell-containing preparations |
| 10/12/2006 | US20060228342 Method for generating antigen-presenting cells |
| 10/12/2006 | US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 10/12/2006 | US20060228334 Modified adenoviral fiber with ablated to cellular receptors |
| 10/12/2006 | US20060228333 Methods for control of tumors and chronic infections by modulating immunologically informed carriers homing to tolerogenic organs or tissues |
| 10/12/2006 | US20060228332 Assembly and folding of Fc-interferon-beta fusion proteins |
| 10/12/2006 | US20060228331 IL-21 Derivatives and variants |
| 10/12/2006 | US20060228330 Dominant negative proteins and methods thereof |
| 10/12/2006 | US20060228329 Homogeneous preparations of IL-31 |